Related references
Note: Only part of the references are listed.EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer
Philip Cornford et al.
EUROPEAN UROLOGY (2021)
Qualitative and quantitative comparison of cell-free DNA and cell-free fetal DNA isolation by four (semi-)automated extraction methods: impact in two clinical applications: chimerism quantification and noninvasive prenatal diagnosis
Pascal Pedini et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2021)
Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms
Hanna Tukachinsky et al.
CLINICAL CANCER RESEARCH (2021)
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
Nicolas Mottet et al.
EUROPEAN UROLOGY (2021)
Exploratory gene-by-gene analysis of olaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): PROfound.
Johann S. De Bono et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Olaparib efficacy in patients with metastatic castration-resistant prostate cancer (mCRPC) carrying circulating tumor (ct) DNA alterations in BRCA1, BRCA2 or ATM: Results from the PROfound study.
Nobuaki Matsubara et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Prostate Cancer, Version 1.2021 Featured Updates to the NCCN Guidelines
Edward Schaeffer et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
An evaluation of current prostate cancer diagnostic approaches with emphasis on liquid biopsies and prostate cancer
Veronica Mollica et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2020)
Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study
Wassim Abida et al.
CLINICAL CANCER RESEARCH (2020)
Germline and somatic mutations in prostate cancer: focus on defective DNA repair, PARP inhibitors and immunotherapy
Alessia Cimadamore et al.
FUTURE ONCOLOGY (2020)
Biomarker analysis of the phase III IPATential150 trial of first-line ipatasertib (Ipat) plus abiraterone (Abi) in metastatic castration-resistant prostate cancer (mCRPC).
Zhen Shi et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Oncologist-led BRCA 'mainstreaming' in the ovarian cancer clinic: A study of 255 patients and its impact on their management
Megan Rumford et al.
SCIENTIFIC REPORTS (2020)
Clinical significance of clonal hematopoiesis in the interpretation of blood liquid biopsy
Hiu Ting Chan et al.
MOLECULAR ONCOLOGY (2020)
Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer
Rodolfo Montironi et al.
CELLS (2020)
Olaparib for Metastatic Castration-Resistant Prostate Cancer
J. de Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
C. Parker et al.
ANNALS OF ONCOLOGY (2020)
Update on Circulating Tumor Cells in Genitourinary Tumors with Focus on Prostate Cancer
Alessia Cimadamore et al.
CELLS (2020)
Assessment of Pre-Analytical Sample Handling Conditions for Comprehensive Liquid Biopsy Analysis
Teresa Gerber et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2020)
Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based ctDNA Assays: A Joint Consensus Recommendation of the BloodPAC's Analytical Variables Working Group
James H. Godsey et al.
CLINICAL CHEMISTRY (2020)
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration
Wassim Abida et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer
Maha Hussain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Isolation of extracellular vesicles improves the detection of mutant DNA from plasma of metastatic melanoma patients
Davide Zocco et al.
SCIENTIFIC REPORTS (2020)
Clonal Hematopoiesis in Liquid Biopsy: From Biological Noise to Valuable Clinical Implications
Hiu Ting Chan et al.
CANCERS (2020)
Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study
Umberto Malapelle et al.
CELLS (2020)
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications
Gaetano Aurilio et al.
CELLS (2020)
Prostate cancer pathology: What has changed in the last 5 years
Alessia Cimadamore et al.
UROLOGIA JOURNAL (2020)
Somatic aberrations of BRCA1 gene are associated with ALDH1, EGFR, and tumor progression in prostate cancer
Aleksandra Omari et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2019)
Genitourinary Tumors: Update on Molecular Biomarkers for Diagnosis, Prognosis and Prediction of Response to Therapy
Alessia Cimadamore et al.
CURRENT DRUG METABOLISM (2019)
Evaluation of Storage Tubes for Combined Analysis of Circulating Nucleic Acids in Liquid Biopsies
Aoife Ward Gahlawat et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy
Alessia Cimadamore et al.
CANCERS (2019)
Germline and Somatic Mutations in Prostate Cancer for the Clinician
Heather H. Cheng et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Circulating Cell-Free DNA and RNA Analysis as Liquid Biopsy: Optimal Centrifugation Protocol
Laure Sorber et al.
CANCERS (2019)
Emerging Biomarkers in Genitourinary Tumors
Rodolfo Montironi et al.
FRONTIERS IN ONCOLOGY (2019)
Re: Gillian Vandekerkhove, Werner J. Struss, Matti Annala, et al. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer. Eur Urol 2019; 75:667-75 How Does Circulating DNA Reach the Blood Stream?
Rodolfo Montironi et al.
EUROPEAN UROLOGY (2019)
Using next-generation sequencing (NGS) platform to diagnose pathogenic germline BRCA1/2 mutations from archival tumor specimens
Pei Yi Ong et al.
GYNECOLOGIC ONCOLOGY (2019)
Comparison of different semi-automated cfDNA extraction methods in combination with UMI-based targeted sequencing
Anna Streubel et al.
Oncotarget (2019)
Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer
Gillian Vandekerkhove et al.
EUROPEAN UROLOGY (2019)
A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications
Anna-Lena Volckmar et al.
GENES CHROMOSOMES & CANCER (2018)
An evaluation of the challenges to developing tumor BRCA1 and BRCA2 testing methodologies for clinical practice
Gillian Ellison et al.
HUMAN MUTATION (2018)
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer
Alexander W. Wyatt et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer
Alexander W. Wyatt et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
False-Positive Plasma Genotyping Due to Clonal Hematopoiesis
Yuebi Hu et al.
CLINICAL CANCER RESEARCH (2018)
Circulating Tumor DNA Assays in Clinical Cancer Research
Miguel R. Ossandon et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA
Davina Gale et al.
PLOS ONE (2018)
Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer
Pedro Isaacsson Velho et al.
PROSTATE (2018)
Comparison of 4 commercial kits for the extraction of circulating DNA from plasma
Kristina Warton et al.
CANCER GENETICS (2018)
Circulating Tumor DNA Assays in Clinical Cancer Research
Miguel R. Ossandon et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection
Clare Fiala et al.
BMC MEDICINE (2018)
Prevalence of clonal hematopoiesis of indeterminate potential (CHIP) measured by an ultra-sensitive sequencing assay: Exploratory analysis of the Circulating Cancer Genome Atlas (CCGA) study.
Charles Swanton et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients
Bente Risberg et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2018)
Evaluation of commercial kits for purification of circulating free DNA
Russell J. Diefenbach et al.
CANCER GENETICS (2018)
Evaluation of Oxford Nanopore's MinION Sequencing Device for Microbial Whole Genome Sequencing Applications
Andrea D. Tyler et al.
SCIENTIFIC REPORTS (2018)
Recent Advances in Liquid Biopsy in Patients With Castration Resistant Prostate Cancer
Vincenzo Di Nunno et al.
FRONTIERS IN ONCOLOGY (2018)
793PDPreliminary results from TRITON2: A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination repair (HRR) gene alterations
W Abida et al.
ANNALS OF ONCOLOGY (2018)
Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease
Joshua Moss et al.
NATURE COMMUNICATIONS (2018)
Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management
Maha Elazezy et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2018)
The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA
Sonya Parpart-Li et al.
CLINICAL CANCER RESEARCH (2017)
Pathology and molecular updates in tumors of the prostate: towards a personalized approach
Silvia Gasparrini et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2017)
Circulating tumor (ct)-DNA alterations in metastatic castration-resistant prostate cancer (mCRPC): Association with outcomes and evolution with therapy.
Guru Sonpavde et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
A Comparison of Cell-Free DNA Isolation Kits Isolation and Quantification of Cell-Free DNA in Plasma
Laure Sorber et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients
Ettore Capoluongo et al.
SEMINARS IN ONCOLOGY (2017)
Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition
Jane Goodall et al.
CANCER DISCOVERY (2017)
cfDNA correlates with endothelial damage after cardiac surgery with prolonged cardiopulmonary bypass and amplifies NETosis in an intracellular TLR9-independent manner
Adnana Paunel-Goerguelue et al.
SCIENTIFIC REPORTS (2017)
New challenges for BRCA testing: a view from the diagnostic laboratory
Andrew J. Wallace
EUROPEAN JOURNAL OF HUMAN GENETICS (2016)
Immunotargeting and personalized therapies in genitourinary cancers
Roberta Mazzucchelli et al.
FUTURE ONCOLOGY (2016)
Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer
Adrian G. Sacher et al.
JAMA ONCOLOGY (2016)
Comparison of methods for circulating cell-free DNA isolation using blood from cancer patients: impact on biomarker testing
Clara Perez-Barrios et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2016)
Comprehensive evaluation of methods to isolate, quantify, and characterize circulating cell-free DNA from small volumes of plasma
Florence Mauger et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2015)
Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
J. Tie et al.
ANNALS OF ONCOLOGY (2015)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse et al.
CELL (2015)
Diagnostic Accuracy of Noninvasive Genotyping of EGFR in Lung Cancer Patients by Deep Sequencing of Plasma Cell-Free DNA
Junji Uchida et al.
CLINICAL CHEMISTRY (2015)
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Aaron M. Newman et al.
NATURE MEDICINE (2014)
Detecting ultralow-frequency mutations by Duplex Sequencing
Scott R. Kennedy et al.
NATURE PROTOCOLS (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
A stabilizing reagent prevents cell-free DNA contamination by cellular DNA in plasma during blood sample storage and shipping as determined by digital PCR
S. E. Norton et al.
CLINICAL BIOCHEMISTRY (2013)
A New Blood Collection Device Minimizes Cellular DNA Release During Sample Storage and Shipping When Compared to a Standard Device
Sheila E. Norton et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2013)
Overcoming mutation-based resistance to antiandrogens with rational drug design
Minna D. Balbas et al.
ELIFE (2013)
Ultrasensitive Measurement of Hotspot Mutations in Tumor DNA in Blood Using Error-Suppressed Multiplexed Deep Sequencing
Azeet Narayan et al.
CANCER RESEARCH (2012)
Detection of ultra-rare mutations by next-generation sequencing
Michael W. Schmitt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
Tim Forshew et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation
Michelle D. Sluiter et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Field guide to next-generation DNA sequencers
Travis C. Glenn
MOLECULAR ECOLOGY RESOURCES (2011)
Detection and quantification of rare mutations with massively parallel sequencing
Isaac Kinde et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Cell-free nucleic acids as biomarkers in cancer patients
Heidi Schwarzenbach et al.
NATURE REVIEWS CANCER (2011)
Genomic rearrangements in BRCA1 and BRCA2: A literature review
Ingrid Petroni Ewald et al.
GENETICS AND MOLECULAR BIOLOGY (2009)
Effects of prolonged storage of whole plasma or isolated plasma DNA on the results of circulating DNA quantification assays
G Sozzi et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Increased concentrations of cell-free plasma DNA after exhaustive exercise
J Atamaniuk et al.
CLINICAL CHEMISTRY (2004)
EDTA is a better anticoagulant than heparin or citrate for delayed blood processing for plasma DNA analysis
NYL Lam et al.
CLINICAL CHEMISTRY (2004)
Share Paper
